Reviva Pharmaceuticals Holdings DEF 14A Filing

TL;DR

Reviva Pharma (RVPH) proxy filed for Dec 10 meeting. Shareholders vote soon.

AI Summary

Reviva Pharmaceuticals Holdings, Inc. filed a definitive proxy statement (DEF 14A) on October 28, 2024, for its annual meeting on December 10, 2024. The company, formerly Tenzing Acquisition Corp. until June 6, 2018, is based in Cupertino, CA, and operates in the pharmaceutical preparations sector.

Why It Matters

This filing provides shareholders with crucial information regarding the upcoming annual meeting, including voting matters and company performance, enabling informed participation in corporate governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing for an annual meeting and does not contain new financial or strategic information that would inherently increase risk.

Key Players & Entities

• REVIVA PHARMACEUTICALS HOLDINGS, INC. (company) — Registrant
• Tenzing Acquisition Corp. (company) — Former Company Name
• 20241210 (date) — Annual Meeting Date
• 20241028 (date) — Filing Date

FAQ

Filing Documents

• rvph20241023_def14a.htm (DEF 14A) — 479KB
• a01.jpg (GRAPHIC) — 111KB
• a02.jpg (GRAPHIC) — 91KB
• capn.jpg (GRAPHIC) — 38KB
• comp.jpg (GRAPHIC) — 38KB
• 0001437749-24-032297.txt ( ) — 863KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 16 2023 Summary Compensation Table 17 Employment Agreements with Our Named Executive Officers 17 Outstanding Equity Awards at Fiscal Year End - 2023 19 PAY VERUS PERFORMANCE 20 DIRECTOR COMPENSATION 23 Director Compensation 23 Non-Employee Director Compensation Policy 23 Indemnification Agreements 24 EQUITY COMPENSATION PLAN INFORMATION 25 2020 Equity Incentive Plan 25 2006 Equity Incentive Plan 25 REPORT OF THE AUDIT COMMITTEE 26

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 27 TRANSACTIONS WITH RELATED PERSONS 29 PROPOSAL 2 31 PROPOSAL 3 34 PROPOSAL 4 35 PROPOSAL 5 36 PROPOSAL 6 38 STOCKHOLDER PROPOSALS 39 ANNUAL REPORT 39 HOUSEHOLDING OF ANNUAL MEETING MATERIALS 39 OTHER MATTERS 40 i REVIVA PHARMACEUTICALS HOLDINGS, INC. 10080 N WOLFE RD., SUITE SW3-200 CUPERTINO, CA 95014 PROXY STATEMENT This proxy statement contains information related to the Annual Meeting of Stockholders (the "Annual Meeting") to be held on Tuesday, December 10, 2024 at 11:00 a.m. Pacific Time. We are planning to hold the Annual Meeting virtually via the Internet, or at such other time and place to which the Annual Meeting may be adjourned or postponed. In order to attend our Annual Meeting, you must log in to www.virtualshareholdermeeting.com/RVPH2024 using the 16-digit control number on the proxy card that accompanied the proxy materials. Proxies for the Annual Meeting are being solicited by the Board of Directors (the "Board") of Reviva Pharmaceuticals Holdings, Inc. (the "Company"). This proxy statement is first being made available to stockholders on or about October 28, 2024. A list of record holders of the Company's common stock entitled to vote at the Annual Meeting will be available for examination by any stockholder, for any purpose germane to the Annual Meeting, at our principal offices at 10080 N Wolfe Rd., Suite SW3-200, Cupertino, CA 95014, during normal business hours for ten days prior to the Annual Meeting and available during the Annual Meeting. IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 10, 2024: Our proxy materials including this proxy statement for the Annual Meeting, our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and the proxy card or voting instruction form are available on the Internet at www.proxyvote.com. Under S